CUAMC
STOK icon

China Universal Asset Management Company’s Stoke Therapeutics STOK Stock Holding History

China Universal Asset Management Company’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$331K Sell
10,112
-5,024
-33% -$161K 0.02% 307
2026
Q1 		$493K Buy
15,136
+2,229
+17% +$73.1K 0.04% 262
2025
Q4 		$410K Buy
12,907
+3,302
+34% +$99.3K 0.03% 278
2025
Q3 		$226K Sell
9,605
-1,361
-12% -$23.3K 0.02% 324
2025
Q2 		$124K Buy
10,966
+342
+3% +$3.25K 0.01% 345
2025
Q1 		$70.7K Sell
10,624
-607
-5% -$5.66K 0.01% 389
2024
Q4 		$124K Buy
+11,231
New +$138K 0.01% 370
2023
Q4 		– Sell
-1,132
Closed -$4.46K – 478
2023
Q3 		$4.46K Buy
1,132
+553
+96% +$3.64K ﹤0.01% 398
2023
Q2 		$6.16K Buy
579
+44
+8% +$468 ﹤0.01% 352
2023
Q1 		$4.46K Buy
535
+134
+33% +$1.21K ﹤0.01% 377
2022
Q4 		$3.7K Buy
401
+32
+9% +$333 ﹤0.01% 333
2022
Q3 		$5K Buy
+369
New +$5.88K ﹤0.01% 277

Other funds holding STOK

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
GIM
Generali Investments Management Ljubljana, Slovenia $460M AUM 29.43% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
YMRC
Yorktown Management & Research Company Forest, Virginia $163M AUM 68.53% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
OCWP
Owl Creek Wealth Partners Denver, Colorado $342M AUM

China Universal Asset Management Company's STOK Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Stoke Therapeutics (STOK) stake by 33% in Q2 2026, selling an estimated $161K and leaving 10,112 shares worth $331K. The position accounts for 0.02% of the portfolio, ranked #307.

China Universal Asset Management Company first reported a position in STOK in Q3 2022 and has held it in 12 quarters since. The position peaked at $493K in Q1 2026. 20 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • China Universal Asset Management Company held 10,112 shares of Stoke Therapeutics worth $331K as of Q2 2026.
  • China Universal Asset Management Company sold 5,024 Stoke Therapeutics shares in Q2 2026, an estimated $161K.
  • Stoke Therapeutics made up 0.02% of China Universal Asset Management Company's portfolio in Q2 2026, its #307 holding.
  • China Universal Asset Management Company first reported a position in Stoke Therapeutics in Q3 2022 and has held it in 12 quarters since.
  • China Universal Asset Management Company's Stoke Therapeutics position peaked at $493K in Q1 2026.
  • 20 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.